The 2017 Japan Atherosclerosis Society guidelines provide evidence-based recommendations for the prevention of ASCVD through lipid management, drug therapy, and lifestyle modifications.
In the subsections on dyslipidemia in the assessment of risk factors, absolute risk of ASCVD, lipid management targets as well as drug therapy and diet therapy in improving lifestyle habits, we created CQs and performed an SR based on the MINDS method. For our SR, we essentially chose the literature published before the end of 2015.
Kinoshita et al. (Tue,) studied this question.